Skip to content

Clinical trials

Amyloid Neuropathies, Familial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloid Neuropathies, Familial Clear all

186 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20081
20101
20111
20122
20137
20143
20152
20166
20176
20186
201915
202014
202116
202215
202322
202425
202517
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting58
Completed53
Unknown status35
Not yet recruiting15
Terminated7
Active, not recruiting6
Enrolling by invitation6
Withdrawn5
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals9
Eidos Therapeutics, a BridgeBio company9
Pfizer7
Brigham and Women's Hospital6
University Hospital Center of Martinique5
University Hospital, Essen5
Steen Hvitfeldt Poulsen4
Assistance Publique - Hôpitaux de Paris3
CENTOGENE GmbH Rostock3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloid Neuropathies, Familial186
Amyloidosis50
Heart Failure23
Cardiomyopathies22
Alzheimer Disease19
Amyloidosis, Familial16
Polyneuropathies15
Amyloid Neuropathies11
Disease10
Immunoglobulin Light-chain Amyloidosis9

Trials

Showing 51 to 75 of 186. Each trial links to its page on Pharma Observatory.

86 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.